bf/NASDAQ:NEXI_icon.jpeg

COM:NEXIMMUNE

NexImmune

  • Stock

Last Close

0.22

21/11 16:09

Market Cap

3.17M

Beta: -

Volume Today

60

Avg: -

NexImmune, Inc., a clinical-stage biotechnology company, engages in developing therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases. It develops approaches to T cell immunotherapies based on its proprietary Artificial Immune Modulation, a nanoparticle technology platform. The company's product candidates include NEXI-001...Show More

competitor of